GX’s special purpose acquisition companies have been formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our management team has deep public and private market expertise. We intend to focus our search on companies: (i) that achieve growth through the application of technology, including late-stage venture companies; (ii) with growth infrastructure opportunities; and (iii) in traditional business lines with a bias toward demonstrated or expected growth.
Main Content
multi-SPAC issuer
GX Acquisition Corp raised $287.5 million in May 2019. GX Acquisition Corp. II raised $300 million in March 2021.
Experienced Team
Led by Jay R. Bloom, Dean C. Kehler and Michael G Maselli, veteran investors with more than 30 years of experience each.
Management Team
Our management team is led by Jay R. Bloom and Dean C. Kehler, our co-Chairmen and Chief Executive Officers, and Michael Maselli, our President. Our management team has guided public and private companies over more than 35 years as private equity principals, owners, corporate directors and advisors across a wide variety of industries, including telecom/media, technology, consumer products and services, financial services, energy, infrastructure, and manufacturing sectors. Through these activities, our management team has developed a broad network of contacts that we believe will be helpful in identifying targets for a potential business combination.
Definitive Agreement
On January 8, 2021, GX Acquisition Corp. entered into a definitive agreement with Celularity, a clinical-stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf allogeneic placenta-derived cellular therapies.